'ROM' p15 Searchterm 'ROM' found in 9 terms [ • ] and 182 definitions [• ]Result Pages : • (AC)
The attenuation correction is usually applied to achieve count rate values independent from tissue densities.
•
Barium sulfate (BaSO4) is an inert and insoluble white powder with high density. Barium belongs chemically to the group of heavy metals. Mixed with water and additional ingredients (e.g., sweetening agents), barium sulfate is the preferred positive contrast agent for abdominal x-ray and computed tomography examinations. The extremely low solubility of barium sulfate protects patients from absorbing harmful amounts of the metal (water soluble metal compounds are often highly toxic). The high density in x-ray examinations is related to the high atomic number, since large nuclei absorb x-rays much better than smaller nuclei. Barium sulfate agents for opacification of the gastrointestinal tract are not absorbed or metabolized and are resistant to dilution. These contrast agents are opaque white suspensions and usually swallowed or administered as an enema. They provide better delineation of mucosal details and are less expensive than water-soluble iodinated contrast media. The elimination rate is a function of gastrointestinal transit time. After GI application, it leaves the body with the feces. Contraindications of barium sulfate products in case of known or suspected:
•
obstruction of the colon;
•
gastrointestinal tract perforation;
•
tracheoesophageal fistula;
•
obstructing lesions of the small intestine;
•
inflammation or neoplastic lesions of the rectum;
•
hypersensitivity to barium sulfate formulations;
•
recent rectal biopsy;
•
pyloric stenosis.
Further Reading: News & More:
•
Baro-Cat® is a barium sulfate suspension for use as an aid for computed tomography of the gastrointestinal tract. The contrast medium contains additional pineapple-banana flavor suspending agents, simethicone, potassium sorbate, citric acid, sorbitol, artificial sweetener and water. Individual technique will determine the suspension quantity and specific procedure used. For computed tomography of the upper gastrointestinal tract should the patient drink 300 mL Baro-Cat® approximately 2 hours before and an additional 300 mL approximately 15 minutes prior to the CT scan. For total bowel opacification the patient should drink additional 300 mL the night before the examination. If rapid transit is desired, administer the suspension chilled. Rectally administered the contrast agent should be at room temperature to body temperature.
Drug Information and Specification
NAME OF COMPOUND
Barium sulfate (BaSO4)
DEVELOPER
Mallinckrodt, Inc.
INDICATION
Bowel opacification
APPLICATION
Oral, rectal
CONCENTRATION
1.5 w/v barium sulfate suspension
300-900 mL
PREPARATION
Ready-to-use product
STORAGE
Store between 15° and 30°C (59° and 86°F); protect from freezing.
PRESENTATION
300, 900 mL bottle
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
•
Beta radiation consists of high energetic electrons or positrons emitted spontaneously from nuclei in decay of some radionuclides. Also called beta particle and sometimes shortened to beta (e.g., beta-emitting radionuclides). Beta radiation is used for example in cancer treatment. The average reach of beta radiation in tissue is 3.5 mm. See also Beta Decay. Further Reading: Basics:
News & More:
•
Biliscopin® Infusion, an iodinated contrast medium for intravenous cholecystography is secreted actively by the hepatocytes. The biliary excretion rate of a biliary contrast medium is determined by the binding to plasma proteins and liver receptor proteins, and by its transport maximum for the liver. Because of its high hepatocellular transport rate, Biliscopin® Infusion leads rapidly to high grade contrast density in the intra-hepatic and extra-hepatic biliary ducts as well as in the gallbladder. Computed tomography with biliary contrast agents provides maximum quality preoperative imaging of the biliary tract.
Drug Information and Specification
NAME OF COMPOUND
Meglumine iotroxate
DEVELOPER
INDICATION
Cholecystography, cholecystangiography
APPLICATION
Intravenous
PHARMACOKINETIC
Biliary excretion
0.29 mosm/kgH2O
IODINE CONCENTRATION
105 mg/mL
100 mL
PREPARATION
Ready-to-use product
STORAGE
Protect from light and x-rays
PRESENTATION
100 mL bottle
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
Result Pages : |